• Distinct Apoptotic Pathways in BMECs Triggered by Candida kr

  2026-05-28

  This study reveals that Candida krusei's yeast and hypha forms induce apoptosis in bovine mammary epithelial cells (BMECs) through fundamentally different signaling pathways. The findings clarify how specific MAPK and innate immune signaling components are differentially engaged depending on the fungal morphotype, offering new direction for targeted research in mastitis pathogenesis and intervention.

• IWP-L6: Mechanistic Insights and Assay Design for Porcupine

  2026-05-28

  Discover how IWP-L6, a potent Porcupine inhibitor, empowers rigorous Wnt signaling modulation for developmental biology and metabolic research. This article uniquely integrates mechanistic depth, protocol design, and the latest reference insights to guide advanced assay applications.

• Tetraethylammonium Chloride: Precision Tool for K+ Channel S

  2026-05-27

  Tetraethylammonium chloride (TEAC) is a gold-standard K+ channel blocker, delivering reproducible inhibition in vascular and electrophysiological assays. Its dual-site mechanism and high purity from APExBIO enable precise mapping of ion conduction pathways and support advanced troubleshooting in pharmacological research.

• Phillygenin Targets Inflammation and Apoptosis in Diabetic N

  2026-05-27

  This study demonstrates that phillygenin, a natural compound, significantly alleviates diabetic nephropathy by suppressing inflammation and apoptosis through modulation of TLR4/MyD88/NF-κB and PI3K/AKT/GSK3β pathways. These findings provide a mechanistic foundation for developing phillygenin as a novel therapeutic agent targeting key molecular drivers of diabetic kidney injury.

• Validating hiPSC-Derived Sensory Neurons for HSV-1 Latency M

  2026-05-26

  This study establishes a scalable human iPSC-derived sensory neuron model for herpes simplex virus 1 (HSV-1) latent infection and reactivation, providing a human-relevant alternative to animal systems. The model enables mechanistic investigations of HSV-1 latency and reactivation, opening new directions for antiviral research and therapeutic development.

• BODIPY 581/591 C11: Ratiometric Probe for Lipid Peroxidation

  2026-05-26

  BODIPY 581/591 C11 empowers researchers to quantify lipid peroxidation and antioxidant capacity in live cell models with ratiometric precision. Its robust spectral shift, high photostability, and specificity for oxygen radicals streamline workflows in ferroptosis and oxidative stress research.

• Population PK/PD Analysis of Vernakalant Hydrochloride in AF

  2026-05-25

  This study presents an integrated population pharmacokinetic–pharmacodynamic (PK/PD) analysis of Vernakalant Hydrochloride (RSD1235) during intravenous treatment of atrial fibrillation (AF) or atrial flutter (AFL). The findings clarify exposure–response relationships for efficacy and safety endpoints, guiding optimized use and translational research.

• Resveratrol’s Hormetic Rescue of Radiation-Induced Endotheli

  2026-05-25

  This study establishes a rapid in vitro model to assess vascular injury caused by ionizing radiation and identifies a hormetic, dose-dependent protective effect of resveratrol on endothelial DNA integrity and tube formation. The findings provide a quantitative framework for optimizing resveratrol dosing in radioprotection and inform assay design for screening natural compounds against endothelial damage.

• TCAIM Regulates Mitochondrial Metabolism via OGDH Degradatio

  2026-05-24

  Wang et al. identify TCAIM as a mitochondrial DNAJC co-chaperone that specifically targets and reduces α-ketoglutarate dehydrogenase (OGDH) protein levels, thereby suppressing TCA cycle activity and altering cellular metabolism. This work reveals a novel post-translational regulatory mechanism for mitochondrial metabolic enzymes, with potential implications for understanding metabolic disease and cellular adaptation.

• AZD2461: Redefining PARP Inhibitor Evaluation in Cancer Mode

  2026-05-23

  Explore how AZD2461, a novel PARP inhibitor, advances breast cancer research by providing unique resistance characteristics and enabling deeper, more accurate drug response profiling. This article reveals practical insights for experimental design that go beyond standard protocols.

• AZD2461: Transforming PARP Inhibition in Translational Oncol

  2026-05-22

  This thought-leadership article dissects the mechanistic, experimental, and translational dimensions of AZD2461, a novel PARP inhibitor with low Pgp affinity. Blending evidence from in vitro and in vivo studies, we guide translational researchers in leveraging AZD2461 to overcome drug resistance and optimize DNA repair targeting, while highlighting advanced evaluation methodologies and future directions in breast cancer research.

• Microfluidized Dextran Microgels Enable Oral Colon Cancer Th

  2026-05-22

  This study presents a dual-targeted microgel system for oral delivery of cisplatin and SPION lipid nanoparticles, selectively releasing the therapeutic cargo in the colon to inhibit tumor growth. The approach demonstrates improved local bioavailability and tumor selectivity compared to conventional chemotherapies, offering a promising avenue for localized colorectal cancer treatment.

• JNK-IN-7 (SKU A3519): Reliable Solutions for Cell Viability

  2026-05-21

  This article provides evidence-based guidance for biomedical researchers and lab technicians using JNK-IN-7 (SKU A3519) in cell viability, apoptosis, and innate immune signaling assays. Drawing on real-world scenarios, it demonstrates how this selective JNK inhibitor—sourced from APExBIO—addresses reproducibility, protocol optimization, and data interpretation challenges in MAPK pathway research.

• Decoding Iron-Sulfur Protein Aconitase: Advanced Insights vi

  2026-05-21

  Explore how the Aconitase Activity Colorimetric Assay Kit enables high-precision analysis of iron-sulfur protein aconitase, bridging metabolic flexibility and oxidative damage insights. This article delivers a unique perspective on assay selection and interpretation for immunometabolism and TCA cycle research.

• Differential Volatile Mechanisms of Chuanxiong Cortex and Pi

  2026-05-20

  This study applies advanced SPME-GC×GC-MS and network pharmacology to dissect the distinct volatile profiles and therapeutic mechanisms of Ligusticum chuanxiong cortex and pith in coronary heart disease (CHD) treatment. The identification of Fenipentol as a key cortex component highlights its potential for gastrointestinal and cardiovascular research.

16634 records 2/1109 page Previous Next 12345 下5页 Last page